chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 86.0
Sex: U
Vaccine: COVID19
Symptoms: Acne
Clinical narrative: after last booster shot 08Mar23, 2-days after shot i started breaking out on the front of the shoulders with small hard pimples; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 86-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Mar2023 at 14:30 as dose 5 (booster), single (Lot number: GK1337) at the age of 86 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Vaccine: 1st COVID-19 , Lot Number: Pfizer EL3246, Date: 12Jan2021, Healthcare Professional or clinic site: (Withheld), DOSE 1, SINGLE), administration date: 12Jan2021, when the patient was 84-year-old, for COVID-19 Immunization; BNT162b2 (Vaccine: 2nd COVID-19 , Lot Number: Pfizer EL9265, Date: 04Feb2021, Healthcare Professional or clinic site: (Withheld)Healthcare Professional or clinic site: (Withheld), DOSE 2, SINGLE, Anatomical site of injection: Left Arm, Route of administration: Intramuscular), administration date: 04Feb2021, when the patient was 84-year-old, for COVID-19 Immunization; BNT162b2 (Vaccine: Other , Lot Number: Pfizer FF2588, Date: 10Sep2021, Healthcare Professional or clinic site: (Withheld), DOSE 3, SINGLE, Anatomical site of injection: RT Arm, Route of administration: Intramuscular), administration date: 10Sep2021, when the patient was 85-year-old, for COVID-19 Immunization; BNT162b2 (Vaccine: Other , Lot Number: Pfizer FJ6369, Date: 12Apr2022, Healthcare Professional or clinic site: (Withheld), DOSE 4, SINGLE, Anatomical site of injection: Left Arm, Route of administration: Intramuscular), administration date: 12Apr2022, when the patient was 85-year-old, for COVID-19 Immunization. The following information was reported: ACNE (non-serious) with onset 08Mar2023 at 16:00, outcome "recovered", described as "after last booster shot 08Mar23, 2-days after shot i started breaking out on the front of the shoulders with small hard pimples". Therapeutic measures were not taken as a result of acne.  Additional information: Reported as, After last booster 08Mar2023, 2 days after shot the patient started breaking out on the front of the shoulders with small hard pimples, about 5 on each sides some more on the side of the neck. The pimples would pop with little effort after about 3 days, then heal. After about 3 days the pimple would come back. After they back the second time they only lasted 2 days, and gone for good.
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Wheezing
Clinical narrative: wheezing; congested; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An 81-year-old male patient received BNT162b2 (BNT162B2), on 22Jan2021 as dose 1, single (Lot number: EL1283) intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "HHT (Hereditary Hemorrhagic Telangiectasia)", start date: 1963 (ongoing), notes: Numerous electrocautery sometimes under sedation ratio most recent was 28Nov2022; "Quad by pass for blocked arteries", start date: 2010 (unspecified if ongoing), notes: Quad by pass-2010 (Cannot take blood thinners due to HHT); "Chronic thromboembolic pulmonary hypertension", start date: Feb2021 (unspecified if ongoing); "Cholesterol" (unspecified if ongoing); "Thyroid" (unspecified if ongoing); "Heart" (unspecified if ongoing); "Nose" (unspecified if ongoing). Concomitant medication(s) included: SIMVASTATIN taken for blood cholesterol abnormal (ongoing); LEVOTHYROXINE taken for thyroid disorder (ongoing); BETAPACE taken for cardiac disorder, start date: 2010 (ongoing); BACTROBAN CREAM nasal taken for nasal disorder (ongoing). The following information was reported: WHEEZING (non-serious), outcome "unknown"; NASAL CONGESTION (non-serious), outcome "unknown", described as "congested". Therapeutic measures were taken as a result of wheezing, nasal congestion.  Additional information: we received our 1st vaccine on 22Jan2021. I had no problem whatsoever. Her husband started wheezing and being congested, we did not suspect it could related to vaccine. We thought he had Bronchitis and the Dr. treated it as such, with antibiotics. He would get better and then it would start all over again. I think it was in May2021, He was diagnosed with Diabetes. The breathing problems continued. We saw a pulmonologist in May2022. He sent for CT with contrast of lungs. Showed blood clots. At that time, I made appts with the director of pulmonology at. He also happens to be the director of the (withheld) at (withheld). Her husband was put on Adempas and is now at full dose. Probably Feb2021, pertinent: We thought (withheld) had Bronchitis in Feb2021. Treated numerous times with antibiotics. In May2022 diagnosed with blood clots in lungs (which we were told actually shown up in Jul2021. We were not informed in '21'. In Jul2022 we went to (withheld) in (withheld). Diagnosed with CTEPH (Chronic thromboembolic pulmonary hypertension). The reason I contacted Pfizer was because I read an article about possible side issues from vaccine being blood clots. It is such a big coincidence I thought I should follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300020963 same patient/product, different event with dose;
Age: 71.0
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: The first 4 were associated with a left axillary enlarged lymph node that developed within a few days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old patient received BNT162b2 (BNT162B2), on 11Feb2021 as dose 1, single (Lot number: EN6201) at the age of 71 years, in left deltoid for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 2021, outcome "recovered" (2021), described as "The first 4 were associated with a left axillary enlarged lymph node that developed within a few days".  Additional information: The first 4 were associated with a left axillary enlarged lymph node that developed within a few days and caused no problems and which resolved within several weeks.
Age: 11.0
Sex: F
Vaccine: MEN
Symptoms: No adverse event, Poor quality product administered, Product storage error
Clinical narrative: temperature excursion due to the thermostat in the refrigerator being accidentally adjusted resulting in a low excursion, MENQUADFI, at a low of 33F out of range for a total of 21 hours with no reported adverse event; administered menquadfi post excursion with no reported adverse event; Initial information received on 09-May-2023 regarding an unsolicited valid non-serious case received from other health professional.  This case is linked to case 2023SA147112.  This case involves a 11 years old female patient who was administered Meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] post temperature excursion due to the thermostat in the refrigerator being accidentally adjusted resulting in a low excursion, at a low of 33F out of range for a total of 21 hours with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Diphtheria vaccine Toxoid, Pertussis vaccine Acellular, Tetanus vaccine Toxoid (TDAP) and Meningococcal vaccine B RFHBP/NADA/NHBA OMV (BEXSERO) both for Prophylactic vaccination.  On 04-May-2023, the patient received 0.5ml dose, total (strength: standard) of suspect Meningococcal A-C-Y-W135 (T CONJ) vaccine Solution for injection of lot U7595AC and expiry: 11-May-2025 via intramuscular route in the left arm for immunization.  From 02-May-2023 to 08-May-2023, the non-serious event of temperature excursion occurred due to the thermostat in the refrigerator being accidentally adjusted resulting in a low excursion, of Meningococcal A-C-Y-W135 (T CONJ) vaccine, at a low of 33F out of range for a total of 21 hours with no reported adverse event (product storage error)(latency: unknown).  On 04-May-2023, the patient developed a non-serious event administered Meningococcal A-C-Y-W135 (T CONJ) vaccine post excursion with no reported adverse event (poor quality product administered) (latency: same day).  Action taken was not applicable.  At time of reporting, the outcome was Unknown for both events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 17.0
Sex: M
Vaccine: MEN
Symptoms: Medication error, No adverse event, Product storage error
Clinical narrative: administered menquadfi post excursion with no reported adverse event; Menquadfi at a low of 33F out of range for a total of 21 hours with no reported adverse event; Initial information received on 09-May-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to case 2023SA146318.  This case involves a 17 years old male patient where (meningococcal a-c-y-w135 (t conj) vaccine) menquadfi at a low of 33f out of range for a total of 21 hours with no reported adverse event and administered menquadfi post excursion with no reported adverse event.  The patient's past medical history, medical treatment(s), concomitant medication(s) and family history were not provided.   On 04-May-2023, the patient received 0.5 ml total (1x) dose of suspect meningococcal a-c-y-w135 (t conj) vaccine Solution for injection (batch number- U7595AC and expiration date- 11-May-2025) via intramuscular route in the right arm (strength : not provided) for Immunization.  On 04-May-2023 menquadfi at a low of 33f out of range for a total of 21 hours with no reported adverse event (product storage error) (latency- same day) following the administration of meningococcal a-c-y-w135 (t conj) vaccine.  On an unknown date the patient got administered menquadfi post excursion with no reported adverse event (poor quality product administered) (unknown latency) following the administration of meningococcal a-c-y-w135 (t conj) vaccine.  Action taken- Not applicable.  At time of reporting, the outcome was Unknown for both the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 3.0
Sex: F
Vaccine: IPV
Symptoms: Medication error, No adverse event, Poor quality product administered, Product storage error
Clinical narrative: the excursion occurred in the fridge that the products are normally stored in, The highest temperature reached 52.5 F and the total excursion lasted 1 hour 30 minutes with no reported adverse event; products were administered post excursion with no reported adverse event; Initial information received on 09-May-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case is linked to case 2023SA145332.  This case involves a 3 years old female patient who had products were administered post excursion with no reported adverse event and the excursion occurred in the fridge that the products are normally stored in, the highest temperature reached 52.5 f and the total excursion lasted 1 hour 30 minutes with no reported adverse event after receiving vaccine IPV (VERO) [IPOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, tetanus vaccine toxoid (infanrix) for Immunisation.  On 18-Apr-2023, the patient received a dose 3, 0.5 ml once of suspect IPV (VERO) Suspension for injection, unknown strength, expiration date and lot V1B89M via intramuscular route in the deltoid nos for Immunization.  On 18-APR-2023 the patient developed a non-serious products were administered post excursion with no reported adverse event (poor quality product administered) (latency: same day). On an unknown date the patient developed a non-serious the excursion occurred in the fridge that the products are normally stored in, the highest temperature reached 52.5 f and the total excursion lasted 1 hour 30 minutes with no reported adverse event (product temperature excursion issue) (unknown latency)   Action taken was not applicable.  Outcome: Unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: IPV
Symptoms: No adverse event, Poor quality product administered, Product storage error
Clinical narrative: the IPOL exposed to an 49.6 Fahrenheit temperature for 12 minutes with no reported adverse event.; the patient received IPOL post excursion with no reported adverse event.; Initial information received on 10-May-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a patient of an unknown age and gender and reporter reported that the IPV (VERO) [IPOL] was exposed to an 49.6 fahrenheit temperature for 12 minutes with no reported adverse event and the patient received ipol post excursion with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received suspect IPV (VERO) for Suspension for injection (with an unknown dosage, frequency, strength, lot: V1A022M, Expiry date: 17-Feb-2024) via unknown route in unknown administration site for immunization (immunization) and the ipol was exposed to an 49.6 fahrenheit temperature for 12 minutes with no reported adverse event. (product storage error) (unknown latency) and the patient received ipol post excursion with no reported adverse event (poor quality product administered) (latency: same day).  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for the events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.83
Sex: F
Vaccine: DTAPIPV
Symptoms: Ear infection, Product administered to patient of inappropriate age
Clinical narrative: ear infection; 10-month old patient received quadracel; Initial information received on 10-May-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 10 months old female patient who experienced ear infection after receiving diphtheria-15/tetanus/5 hybrid AC pertussis/IPV (MRC5) vaccine [Quadracel] and it was reported that 10-month old patient received quadracel.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included hepatitis B vaccine; and pneumococcal vaccine CONJ 7V (CRM197) (Prevnar) both for Immunisation.  On 28-Mar-2023, the 10-month old patient received 0.5 mL of suspect diphtheria-15/tetanus/5 hybrid AC pertussis/IPV (MRC5) vaccine [Quadracel] Suspension for injection (batch/lot number: C5970AA; expiry date: 02-Feb-2024; strength: standard; 1X) via intramuscular route in the left thigh for immunization (product administered to patient of inappropriate age) (latency: same day).   On an unknown date, the patient developed event ear infection (unknown latency) following the administration of diphtheria-15/tetanus/5 hybrid AC pertussis/IPV (MRC5) vaccine.  Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event (ear infection).  At time of reporting, the outcome was Unknown for the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Flushing, Hyperhidrosis
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild
Age: 83.0
Sex: F
Vaccine: TDAP
Symptoms: Pertussis, Pneumonia, Pyrexia
Clinical narrative: Systemic: Fever-Severe, Systemic: developed whooping cough/pneumonia-Severe
Age: 92.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild
Age: 2.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: wrong moderna bivalent admistered. patient was outreached. appointment scheduled for 6/3/23
Age: 8.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: newly FDA (Food and Drug Administration) authorized Moderna bivalent formulation has a slightly higher dosage than what their child recently received. According to the guidelines from the CDC (Centers for Disease Control and Prevention), it is recommended that we repeat their child?s most recent dose of COVID-19 vaccine to ensure proper protection.  No adverse effects noted.
Age: 4.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: admin wrong modern bivalent, outreached to revaccinate
Age: 2.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: moderna bivalent given, patient was outreached and scheduled to come in on 6/3/23
Age: 4.0
Sex: F
Vaccine: COVID19-2, DTAPIPV, PNC13
Symptoms: Underdose
Clinical narrative: Pt received Moderna bivalent formulation was administered with a lower dose than recommended. Appt has been scheduled for pt to revaccinate.
Age: 3.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: admin wrong Moderna bivalent vaccine, patient was outreached to vaccinate again.
Age: 0.75
Sex: F
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: patient was given moderna bivalent, patient was outreached and will be coming back on 6/21/23
Age: 3.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: admin wrong moderna bivalent, outreached to patient. schedule for 06/03/2023 for right vaccination
Age: 3.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: The newly FDA (Food and Drug Administration) authorized Moderna bivalent formulation has a slightly higher dosage than what their child recently received.  According to the guidelines from the CDC (Centers for Disease Control and Prevention), it is recommended that we repeat their child?s most recent dose of COVID-19 vaccine to ensure proper protection. No adverse effects
Age: 2.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Pt received Moderna bivalent formulation was administered with a lower dose than recommended. Appt has been scheduled for pt to revaccinate.
Age: 0.83
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: patient was given moderna bivalent vaccine, patient was outreached and is coming back to clinic on 6/3/23
Age: 0.58
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: the newly FDA (Food and Drug Administration) authorized Moderna bivalent formulation has a slightly higher dosage than what their child recently received.  According to the guidelines from the CDC (Centers for Disease Control and Prevention), it is recommended that we repeat their child?s most recent dose of COVID-19 vaccine to ensure proper protection.
Age: 5.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Moderna bivalent formulation was administered with a lower dose than recommended. Appt has been scheduled for pt to revaccinate.
Age: 4.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: the newly FDA (Food and Drug Administration) authorized Moderna bivalent formulation has a slightly higher dosage than what their child recently received.  According to the guidelines from the CDC (Centers for Disease Control and Prevention), it is recommended that we repeat their child?s most recent dose of COVID-19 vaccine to ensure proper protection. No adverse reaction noted
Age: 75.0
Sex: F
Vaccine: RAB
Symptoms: Blood culture, Blood lactic acid, Chest X-ray, Computerised tomogram head, Electrocardiogram
Clinical narrative: nausea,  headache, myalgia started the evening of administration, she received second dose 5/11/23, had worsening headache, myalgias, nausea, also developed urticaria about 4 hours after second dose administration
Age: 75.0
Sex: F
Vaccine: RAB
Symptoms: Full blood count, Headache, Influenza A virus test negative, Influenza B virus test, Metabolic function test
Clinical narrative: nausea,  headache, myalgia started the evening of administration, she received second dose 5/11/23, had worsening headache, myalgias, nausea, also developed urticaria about 4 hours after second dose administration
Age: 75.0
Sex: F
Vaccine: RAB
Symptoms: Myalgia, Nausea, Respiratory syncytial virus test negative, SARS-CoV-2 test negative, Urticaria
Clinical narrative: nausea,  headache, myalgia started the evening of administration, she received second dose 5/11/23, had worsening headache, myalgias, nausea, also developed urticaria about 4 hours after second dose administration
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral haemorrhage, Death
Clinical narrative: Brain Bleed on April 13 2022 and died April 17 2022
Age: 76.0
Sex: M
Vaccine: HEPAB, VARZOS
Symptoms: Swollen tongue
Clinical narrative: tongue swelling
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Joint stiffness, Lymphadenopathy, Tenderness
Clinical narrative: swelling in lymph nodes of Left arm (size of golf ball), joint stiffness, tenderness
Age: 1.5
Sex: M
Vaccine: HIBV, MMR, TDAP
Symptoms: Diarrhoea, Pyrexia, Wrong product administered
Clinical narrative: Patient received a Tdap instead of Dtap by error, mother complained of Fever, Diarrhea was seen in ER and also office visit follow up the next day.
Age: 4.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Aphasia, Autism spectrum disorder, Developmental delay, Loss of personal independence in daily activities, Unresponsive to stimuli
Clinical narrative: Pt, who was a successful student at a Montessori school, who fluently spoke 3 languages, and who was skipped a class due to his high achievent, suddently stopped speaking all together a few days after receiving the MMR II shot; he stopped following verbal or non verbal directions/instructions and cues; he stopped functioning all together.  Numerous visits to psychologists and specialists doctors revealed that he became autistic as a result of the MMR II shot.
Age: 35.0
Sex: F
Vaccine: HPV9
Symptoms: Pain, Pain in extremity
Clinical narrative: Sore arm upon exertion and laying upon the arm. Rates the pain 7/10.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: no adverse reactions, no abnormal symptoms . All patients advised to wait in clinic lobby for 20 min after vaccinations or medication administration.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Blindness, Dysstasia, Laboratory test, Musculoskeletal disorder, Visual impairment
Clinical narrative: Legs quit 2 days after 2nd vaccination, could not stand up alone. Eyesight became worse and worse til now legally blind.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Walking aid user
Clinical narrative: Legs quit 2 days after 2nd vaccination, could not stand up alone. Eyesight became worse and worse til now legally blind.
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vertigo
Clinical narrative: I do not know if vertigo has anything to do with this vaccine and don't blame a vaccine for it.  I'm only doing this report because I got a follow-up call from vaccine study. I have vertigo. It started  approx 1/15/23. I went to the doctor on 2/1/23 and was given Fluticasone Propionate nose spray and Meclizine. I got better for a couple weeks and then it came back. I have it right now and will have to go back to the doctor.
Age: 77.0
Sex: F
Vaccine: PNC20, TDAP
Symptoms: Administration site pain, Axillary pain, Injection site pruritus, Injection site swelling, Pyrexia
Clinical narrative: A week later after the vaccine administration, the patient came to the pharmacy complaining  that she suffered of fever,  pain at the site of administration, swelling of the injection side,  pain under the arm  and itching at the injection site area.
Age: 48.0
Sex: M
Vaccine: UNK
Symptoms: Bacterial infection, Blood test normal, Corneal scar, Eye infection viral, Eye pain
Clinical narrative: First symptom was pain between the right temple and the eye on 4/22 at 10pm.  Pain was deep behind the eye and persisted for weeks. Few days after I got little bit of rash on my forehead only on the right side.  Next day I got even more rash and decided to see a doctor (Item 14) which diagnosed me with Shingles on 4/ 26 at 9am and prescribed Valacyclovir 1000mg.  I was also seen by optomologist DO the same day at 1:15pm and my eye was fine. Two days after doctor (item 14) prescribed antibacterial cream to put in my eye as I complained about  eye pain, this was over the phone.  On morning of 4/29 my eye was swollen and it was hard to open because I got a bacterial infection as a complication and went to the Urgent Care. Urgent care doctor prescribed oral antibiotic and eye drops instead of eye cream I used before. Oral antibiotic worked but cream caused my eye to get bloody in the white part so I stopped putting drops in my eye.  ]On 5/2 I went to the ER and was seen by MD as I got very foggy vision in my right eye and they found the virus in my eye using a visual acuity screening. They refilled my Valacyclovir and told me to put same cream antibiotic in my eye as before, not to take eye drops that caused blood in my eyes and prescribed antiviral eye drops.  On 5/8 I went to see the optomologist MD and complained about not being able to sleep for 3 days because of itching and numbness on my forehead and eyebrow so he prescribed 600mg gabapentin.  He also found virus scaring on my cornea on the side and center and told me that this is a lifelong disease and that the virus is only dormant and can start causing damage again at any time.  On 5/10 I went to see neurologist Dr and she confirmed postherpetic neuralgia and told me to take Gabapentin.  I still have numbness and itching and can't sleep without a lot of medication to put me to sleep. It is very hard for me to work as I have sensitivity to light and can't look at the screen without taking pain medication. All my daily activities are heavily impaired and I can hardly do anything because of light sensitivity and pain. On the day when I got the Tdap vaccine I was fine and my blood tests were normal. Tdap vaccine was given to me on a yearly physical exam while visiting Drs by a nurse. My uneducated guess would be that Tdap vaccine caused my immune system to drop and that caused Shingles to appear earlier than my age would suggest.  Impaired immune system also caused all these side issues like bacterial infection, virus to infect my eye, forehead and eyebrow numbness and itching which normally happens with people with weak immune system.  My blood test before the vaccine was normal so there is no reason to believe my immune system was impaired before and I was not sick for very long time.
Age: 48.0
Sex: M
Vaccine: UNK
Symptoms: Eye swelling, Eyelid function disorder, Headache, Herpes zoster, Hypoaesthesia
Clinical narrative: First symptom was pain between the right temple and the eye on 4/22 at 10pm.  Pain was deep behind the eye and persisted for weeks. Few days after I got little bit of rash on my forehead only on the right side.  Next day I got even more rash and decided to see a doctor (Item 14) which diagnosed me with Shingles on 4/ 26 at 9am and prescribed Valacyclovir 1000mg.  I was also seen by optomologist DO the same day at 1:15pm and my eye was fine. Two days after doctor (item 14) prescribed antibacterial cream to put in my eye as I complained about  eye pain, this was over the phone.  On morning of 4/29 my eye was swollen and it was hard to open because I got a bacterial infection as a complication and went to the Urgent Care. Urgent care doctor prescribed oral antibiotic and eye drops instead of eye cream I used before. Oral antibiotic worked but cream caused my eye to get bloody in the white part so I stopped putting drops in my eye.  ]On 5/2 I went to the ER and was seen by MD as I got very foggy vision in my right eye and they found the virus in my eye using a visual acuity screening. They refilled my Valacyclovir and told me to put same cream antibiotic in my eye as before, not to take eye drops that caused blood in my eyes and prescribed antiviral eye drops.  On 5/8 I went to see the optomologist MD and complained about not being able to sleep for 3 days because of itching and numbness on my forehead and eyebrow so he prescribed 600mg gabapentin.  He also found virus scaring on my cornea on the side and center and told me that this is a lifelong disease and that the virus is only dormant and can start causing damage again at any time.  On 5/10 I went to see neurologist Dr and she confirmed postherpetic neuralgia and told me to take Gabapentin.  I still have numbness and itching and can't sleep without a lot of medication to put me to sleep. It is very hard for me to work as I have sensitivity to light and can't look at the screen without taking pain medication. All my daily activities are heavily impaired and I can hardly do anything because of light sensitivity and pain. On the day when I got the Tdap vaccine I was fine and my blood tests were normal. Tdap vaccine was given to me on a yearly physical exam while visiting Drs by a nurse. My uneducated guess would be that Tdap vaccine caused my immune system to drop and that caused Shingles to appear earlier than my age would suggest.  Impaired immune system also caused all these side issues like bacterial infection, virus to infect my eye, forehead and eyebrow numbness and itching which normally happens with people with weak immune system.  My blood test before the vaccine was normal so there is no reason to believe my immune system was impaired before and I was not sick for very long time.
Age: 48.0
Sex: M
Vaccine: UNK
Symptoms: Immune system disorder, Impaired work ability, Insomnia, Loss of personal independence in daily activities, Pain
Clinical narrative: First symptom was pain between the right temple and the eye on 4/22 at 10pm.  Pain was deep behind the eye and persisted for weeks. Few days after I got little bit of rash on my forehead only on the right side.  Next day I got even more rash and decided to see a doctor (Item 14) which diagnosed me with Shingles on 4/ 26 at 9am and prescribed Valacyclovir 1000mg.  I was also seen by optomologist DO the same day at 1:15pm and my eye was fine. Two days after doctor (item 14) prescribed antibacterial cream to put in my eye as I complained about  eye pain, this was over the phone.  On morning of 4/29 my eye was swollen and it was hard to open because I got a bacterial infection as a complication and went to the Urgent Care. Urgent care doctor prescribed oral antibiotic and eye drops instead of eye cream I used before. Oral antibiotic worked but cream caused my eye to get bloody in the white part so I stopped putting drops in my eye.  ]On 5/2 I went to the ER and was seen by MD as I got very foggy vision in my right eye and they found the virus in my eye using a visual acuity screening. They refilled my Valacyclovir and told me to put same cream antibiotic in my eye as before, not to take eye drops that caused blood in my eyes and prescribed antiviral eye drops.  On 5/8 I went to see the optomologist MD and complained about not being able to sleep for 3 days because of itching and numbness on my forehead and eyebrow so he prescribed 600mg gabapentin.  He also found virus scaring on my cornea on the side and center and told me that this is a lifelong disease and that the virus is only dormant and can start causing damage again at any time.  On 5/10 I went to see neurologist Dr and she confirmed postherpetic neuralgia and told me to take Gabapentin.  I still have numbness and itching and can't sleep without a lot of medication to put me to sleep. It is very hard for me to work as I have sensitivity to light and can't look at the screen without taking pain medication. All my daily activities are heavily impaired and I can hardly do anything because of light sensitivity and pain. On the day when I got the Tdap vaccine I was fine and my blood tests were normal. Tdap vaccine was given to me on a yearly physical exam while visiting Drs by a nurse. My uneducated guess would be that Tdap vaccine caused my immune system to drop and that caused Shingles to appear earlier than my age would suggest.  Impaired immune system also caused all these side issues like bacterial infection, virus to infect my eye, forehead and eyebrow numbness and itching which normally happens with people with weak immune system.  My blood test before the vaccine was normal so there is no reason to believe my immune system was impaired before and I was not sick for very long time.
Age: 48.0
Sex: M
Vaccine: UNK
Symptoms: Photophobia, Post herpetic neuralgia, Pruritus, Rash, Sleep disorder
Clinical narrative: First symptom was pain between the right temple and the eye on 4/22 at 10pm.  Pain was deep behind the eye and persisted for weeks. Few days after I got little bit of rash on my forehead only on the right side.  Next day I got even more rash and decided to see a doctor (Item 14) which diagnosed me with Shingles on 4/ 26 at 9am and prescribed Valacyclovir 1000mg.  I was also seen by optomologist DO the same day at 1:15pm and my eye was fine. Two days after doctor (item 14) prescribed antibacterial cream to put in my eye as I complained about  eye pain, this was over the phone.  On morning of 4/29 my eye was swollen and it was hard to open because I got a bacterial infection as a complication and went to the Urgent Care. Urgent care doctor prescribed oral antibiotic and eye drops instead of eye cream I used before. Oral antibiotic worked but cream caused my eye to get bloody in the white part so I stopped putting drops in my eye.  ]On 5/2 I went to the ER and was seen by MD as I got very foggy vision in my right eye and they found the virus in my eye using a visual acuity screening. They refilled my Valacyclovir and told me to put same cream antibiotic in my eye as before, not to take eye drops that caused blood in my eyes and prescribed antiviral eye drops.  On 5/8 I went to see the optomologist MD and complained about not being able to sleep for 3 days because of itching and numbness on my forehead and eyebrow so he prescribed 600mg gabapentin.  He also found virus scaring on my cornea on the side and center and told me that this is a lifelong disease and that the virus is only dormant and can start causing damage again at any time.  On 5/10 I went to see neurologist Dr and she confirmed postherpetic neuralgia and told me to take Gabapentin.  I still have numbness and itching and can't sleep without a lot of medication to put me to sleep. It is very hard for me to work as I have sensitivity to light and can't look at the screen without taking pain medication. All my daily activities are heavily impaired and I can hardly do anything because of light sensitivity and pain. On the day when I got the Tdap vaccine I was fine and my blood tests were normal. Tdap vaccine was given to me on a yearly physical exam while visiting Drs by a nurse. My uneducated guess would be that Tdap vaccine caused my immune system to drop and that caused Shingles to appear earlier than my age would suggest.  Impaired immune system also caused all these side issues like bacterial infection, virus to infect my eye, forehead and eyebrow numbness and itching which normally happens with people with weak immune system.  My blood test before the vaccine was normal so there is no reason to believe my immune system was impaired before and I was not sick for very long time.
Age: 48.0
Sex: M
Vaccine: UNK
Symptoms: Vision blurred, Visual acuity tests abnormal
Clinical narrative: First symptom was pain between the right temple and the eye on 4/22 at 10pm.  Pain was deep behind the eye and persisted for weeks. Few days after I got little bit of rash on my forehead only on the right side.  Next day I got even more rash and decided to see a doctor (Item 14) which diagnosed me with Shingles on 4/ 26 at 9am and prescribed Valacyclovir 1000mg.  I was also seen by optomologist DO the same day at 1:15pm and my eye was fine. Two days after doctor (item 14) prescribed antibacterial cream to put in my eye as I complained about  eye pain, this was over the phone.  On morning of 4/29 my eye was swollen and it was hard to open because I got a bacterial infection as a complication and went to the Urgent Care. Urgent care doctor prescribed oral antibiotic and eye drops instead of eye cream I used before. Oral antibiotic worked but cream caused my eye to get bloody in the white part so I stopped putting drops in my eye.  ]On 5/2 I went to the ER and was seen by MD as I got very foggy vision in my right eye and they found the virus in my eye using a visual acuity screening. They refilled my Valacyclovir and told me to put same cream antibiotic in my eye as before, not to take eye drops that caused blood in my eyes and prescribed antiviral eye drops.  On 5/8 I went to see the optomologist MD and complained about not being able to sleep for 3 days because of itching and numbness on my forehead and eyebrow so he prescribed 600mg gabapentin.  He also found virus scaring on my cornea on the side and center and told me that this is a lifelong disease and that the virus is only dormant and can start causing damage again at any time.  On 5/10 I went to see neurologist Dr and she confirmed postherpetic neuralgia and told me to take Gabapentin.  I still have numbness and itching and can't sleep without a lot of medication to put me to sleep. It is very hard for me to work as I have sensitivity to light and can't look at the screen without taking pain medication. All my daily activities are heavily impaired and I can hardly do anything because of light sensitivity and pain. On the day when I got the Tdap vaccine I was fine and my blood tests were normal. Tdap vaccine was given to me on a yearly physical exam while visiting Drs by a nurse. My uneducated guess would be that Tdap vaccine caused my immune system to drop and that caused Shingles to appear earlier than my age would suggest.  Impaired immune system also caused all these side issues like bacterial infection, virus to infect my eye, forehead and eyebrow numbness and itching which normally happens with people with weak immune system.  My blood test before the vaccine was normal so there is no reason to believe my immune system was impaired before and I was not sick for very long time.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: Patient reported injection site soreness for 2 days and red, swelling, rash for 7 days from shoulder to the elbow on the injection arm. patient contacted doctor and was instructed to use cortisone carem to relief the symptoms. All the symptoms are gone and recovered reported by patient on 05/13/2023.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Gait disturbance, Pain
Clinical narrative: PT HAD EXTREME PAIN IN ENITRE BODY COULD, WAS DIFCULT TO WALK BUT IS BETTER NOW
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Aphasia, Blood test, Brain fog, Cognitive disorder, Computerised tomogram thorax
Clinical narrative: 72 hour fever 103-100.  Prolonged fatigue, shortness of breath with minimal exertion, Brain fog, difficulty with math calculations, word finding., continued to worsen rather than diminish over these last  12 months.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea, Dyspnoea exertional, Fatigue, General physical health deterioration, Pyrexia
Clinical narrative: 72 hour fever 103-100.  Prolonged fatigue, shortness of breath with minimal exertion, Brain fog, difficulty with math calculations, word finding., continued to worsen rather than diminish over these last  12 months.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema, Complement factor C4, Pharyngeal swelling, Tryptase
Clinical narrative: Angioedema spontaneous, random, initially occurring more localized- half of tongue, half of upper lip, lower lip, as time went by the occurrences became more frequent up to weekly, involving wider areas, whole tongue, last one was throat swelling and need for epi pen. I was given  - 1 Pepcid 20 mg am - 2 Zyrtec pm - 1 singulair pm - 1 Pepcid 20 mg pm - At symptoms: Benadryl 50 mg, 2 Zyrtec Despite all that, the episodes continued, more severe and more often. I was started on Xolair a week ago. So far, last attack with throat swelling, was few days before that, so about 10 days ago.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Headache, Pain, Pyrexia
Clinical narrative: Severe Body ache Mild headache  Low grade fever 100.5ish Tired
Age: 61.0
Sex: M
Vaccine: PNC20
Symptoms: Extra dose administered, No adverse event
Clinical narrative: It was discovered on 05/13/23 that patient was given a second dose of Prevnar by mistake on 05/05/23. Per The Immunization System, patient has already gotten 1 dose of Prevnar 20 on 10/12/2022. Patient's record from pharmacy dispensing system also confirmed the aforementioned error. Patient was contacted regarding this incident and reported no adverse side effects since his 2nd dose of Prevnar 20.
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chest pain, Dyspnoea exertional, Fatigue, Full blood count, Lung infiltration
Clinical narrative: Pt. reported to PHN that she developed chest pain and SOB on exertions on 5/6/2023 in morning.  Pt. reports she has had 2 episodes of partial lobal lung collapse in rt lung "many years ago".She is a retired doctor/radiation oncologist, and felt the symptoms were not cardiac in origin.  She waited until Monday morning and didn't feel better, so she went to her regular NP and cbc, complete metabolic panel and x-ray was taken. Infiltrate in lingula seen. She was dx with pneumonia and prescribed  augmentin x 7 days and erythromycin x  5 days. She told NP that she had had the Moderna vaccine the day before sx start and asked if she could have gotten pneumonia from it. The NP said they were not certain if the vaccine caused the pneumonia or not. Pt. states the pneumonia symptoms resolved after 1 week, but still feels fatigued.  Pt. reports she feels 90% recovered after 1 week. PHN advised this should  be reported to VAERSand pt asked for PHN assistance in reporting.
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Metabolic function test, Pneumonia, X-ray
Clinical narrative: Pt. reported to PHN that she developed chest pain and SOB on exertions on 5/6/2023 in morning.  Pt. reports she has had 2 episodes of partial lobal lung collapse in rt lung "many years ago".She is a retired doctor/radiation oncologist, and felt the symptoms were not cardiac in origin.  She waited until Monday morning and didn't feel better, so she went to her regular NP and cbc, complete metabolic panel and x-ray was taken. Infiltrate in lingula seen. She was dx with pneumonia and prescribed  augmentin x 7 days and erythromycin x  5 days. She told NP that she had had the Moderna vaccine the day before sx start and asked if she could have gotten pneumonia from it. The NP said they were not certain if the vaccine caused the pneumonia or not. Pt. states the pneumonia symptoms resolved after 1 week, but still feels fatigued.  Pt. reports she feels 90% recovered after 1 week. PHN advised this should  be reported to VAERSand pt asked for PHN assistance in reporting.
Age: 81.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Antiacetylcholine receptor antibody positive, Antibody test, Blood thyroid stimulating hormone, Eyelid disorder, Impaired driving ability
Clinical narrative: First identified something was wrong on Jan 22, 2023 when left eyelid came down obscuring vision and vision became blurry, while driving. PCP visit Jan 25, 2023 ran tests. Ophthalmology visit on Jan 31, 2023 at local eye institute with Dr. who examined me while actually having a repeat episode (now continual) diagnosed it as myasthenia gravis and ordered the following tests: acetylcholine receptor abs reflex panel, acetylcholine receptor modulating ab reflex only, musk quantitative antibody, TSH w/reflex to free t4 (if abnormal), oct optic nerve. Tests came back showing that I was antibody-positive myasthenia gravis. Since then I have been under treatment by Dr. at neuro ophthalmologist at local eye institute. Before the first episode occurred I noticed sensitivity to the winter evening sun which I had never noticed before in previous winters so that may have been an early indicator that something had changed after the vaccination on Oct 5, 2022. Dr., neuro-ophthalmologist, local eye institute. Blood test results for myasthenia gravis: ACh-R modulating 76. AChR binding 9.9, ACh-R blocking 45, MUSK 0.0, TSH 4.07
Age: 81.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Laboratory test, Myasthenia gravis, Vision blurred, Visual impairment
Clinical narrative: First identified something was wrong on Jan 22, 2023 when left eyelid came down obscuring vision and vision became blurry, while driving. PCP visit Jan 25, 2023 ran tests. Ophthalmology visit on Jan 31, 2023 at local eye institute with Dr. who examined me while actually having a repeat episode (now continual) diagnosed it as myasthenia gravis and ordered the following tests: acetylcholine receptor abs reflex panel, acetylcholine receptor modulating ab reflex only, musk quantitative antibody, TSH w/reflex to free t4 (if abnormal), oct optic nerve. Tests came back showing that I was antibody-positive myasthenia gravis. Since then I have been under treatment by Dr. at neuro ophthalmologist at local eye institute. Before the first episode occurred I noticed sensitivity to the winter evening sun which I had never noticed before in previous winters so that may have been an early indicator that something had changed after the vaccination on Oct 5, 2022. Dr., neuro-ophthalmologist, local eye institute. Blood test results for myasthenia gravis: ACh-R modulating 76. AChR binding 9.9, ACh-R blocking 45, MUSK 0.0, TSH 4.07